Contract Research

Century Pharma Ltd., recognised as the Best Pharmaceutical Company in India, offers specialised Contract Research Services in India to support pharmaceutical innovation and development. With deep scientific expertise and advanced infrastructure, we assist our partners in discovering and developing high-quality Active Pharmaceutical Ingredients (APIs), formulations, and intermediates tailored to global regulatory standards. Our research capabilities span method development, stability studies, impurity profiling, and more.

As one of the leading Antibiotic API Manufacturers in India, we understand the critical role of R&D in developing robust and effective pharmaceutical solutions. Our contract research team works collaboratively with clients to streamline the development pipeline, reduce costs, and improve efficiency, ensuring faster, reliable results. We follow a customer-centric approach, offering flexible engagement models and transparent processes to meet your specific research goals.

Recognised as India’s No.1 Pharmaceutical Company, Century Pharma is your trusted partner for high-end contract research. Our commitment to scientific excellence, confidentiality, and regulatory compliance makes us a preferred choice for companies seeking reliable and innovative research solutions. Let us help you accelerate your pharmaceutical product development journey with confidence and precision.

  • In vitro Assay development for signal transduction, anti-inflammation, and anti-cancer:
    Development of targeted in vitro assays to study cellular signalling pathways, inflammation, and cancer mechanisms.
  • Immunological assays:
    Design and execution of immunological assays to evaluate immune responses and biomarker activity.
  • Investigational Research for medical problems:
    Customised research to explore novel solutions and therapeutic approaches for unresolved medical challenges.
  • In vitro Proof of concept studies:
    Early-stage in vitro experiments to validate the feasibility and effectiveness of drug candidates or therapies.
  • Laboratory scale:
    Small-scale laboratory experimentation to assess formulation, synthesis, or process viability before scaling.
  • Process development for bacterial fermentation:
    Optimisation of upstream processes for efficient bacterial fermentation in API and intermediate production.
  • Downstream development:
    Refinement of purification and recovery techniques for isolating and processing target compounds post-fermentation.

  • Cell culture: Expertise in developing and maintaining diverse cell lines for research and production applications.
  • Assay development: Proven capability in designing, validating, and optimising robust analytical and bioassays.
  • New product development: End-to-end support for innovating and formulating new pharmaceutical products from concept to launch.
  • Process development: Advanced solutions for scaling and optimising manufacturing processes to ensure efficiency and quality.

  • DSIR, India recognised R&D
  • Functional Institutional Biosafety Committee
  • Functional Institutional Committee for Stem Cell Research
  • Applied for FDA/CDSCO approval Stem Cell Facility
  • Excellence for Innovation, Quality, Productivity, Management (IES, India)
  • Gold Award from Lockheed Martin for Best Innovation in Biotech Technology, August 2007
  • Innovation 100 organisation in the year 2014 was published by 9dot9 Media

Download Brochure